natgillin/translations-raw huggingface dataset:
Skin and subcutaneous tissue disorders common hyperhidrosis uncommon cold sweat, dry skin, rash, skin lesion, ecchymosis*
Poremećaji kože i potkožnog tkiva često hiperhidroza manje često hladan znoj, suha koža, osip, kožna lezija, ekhimoza*
Subcutaneous use
sublingvalni buprenorfin
Instruct the patient that the pressure bandage can be removed after 24 hours and the adhesive bandage in three to five days.
Bolesniku dajte uputu da ukloni kompresijski zavoj nakon 24 sata, a flaster nakon tri do pet dana.
While applying counter-traction to the skin, at a slight angle (no greater than 20 degrees), insert only the tip of the applicator into the subcutaneous space (depth of 3 to 4 mm below the skin), with the bevel-up stop marking on the cannula facing upwards and visible with the obturator locked fully into the cannula (Figure 5).
Povlačeći kožu na suprotnu stranu, uvedite vršak aplikatora pod malim kutom (ne većim od 20 stupnjeva) u potkožni prostor (dubine 3-4 mm ispod kože), tako da urezana oznaka za zaustavljanje na držaču kanile gleda prema gore i da je vidljivo kako je opturator potpuno pričvršćen u kanili (slika 5).
• have severly reduced liver function
• ako imate jako smanjenu funkciju jetre
Sixmo implants are intended to be in place for 6 months of treatment and provide a sustained delivery of buprenorphine.
Implantati Sixmo predviđeni su da ostanu na mjestu ugradnje tijekom 6 mjeseci liječenja i osiguravaju kontinuirano otpuštanje buprenorfina.
A key secondary endpoint in Study PRO-806 was the difference in proportions of urine samples that were negative for opioids over 24 weeks for Sixmo versus sublingual buprenorphine.
Ključna sekundarna mjera ishoda u ispitivanju PRO-806 bila je razlika u udjelu uzoraka mokraće koji su bili negativni na opioide tijekom 24 tjedna u skupini koja je imala ugrađen Sixmo naspram one koja je primala sublingvalni buprenorfin.
• enlarged prostate or narrowed urethra
• povećanu prostatu ili suženu mokraćnu cijev
• mild or moderate liver problems
• blage ili umjerene probleme s jetrom
Figure 1: Cumulative Distribution Function of the Percentage of Urine Samples Negative for Opioids in Weeks 1-16, Study PRO-805 (ITT)
Slika 1: Kumulativna funkcija distribucije postotka uzoraka mokraće negativnih na opioide u razdoblju od 1. do 16. tjedna, ispitivanje PRO-805 (ITT)
Caution is recommended when dosing patients with severe renal impairment (creatinine clearance < 30 mL/min) (see sections 4.4 and 5.2).
Preporučuje se oprez kod primjene u bolesnika s teškim oštećenjem bubrežne funkcije (klirens kreatinina < 30 ml/min) (vidjeti dijelove 4.4 i 5.2).
• Benzodiazepines: This combination may result in death due to respiratory depression of central origin.
“azepam” Ta kombinacija može dovesti do smrti zbog depresije disanja.
Prescription opioids * For 1 patient (0.8%) primary opioid of abuse was “other”.
Medijan dobi (raspon), godine Primarni opioid zlouporabe, n (%) heroin opioidni lijekovi koji se izdaju na recept * Za 1 bolesnika (0,8%) primarni opioid zlouporabe bilo je “ostalo”.
ITT=intent-to-treat Buprenorphine was not included in urine toxicology assessments.
Buprenorfin nije bio uključen u toksikološke analize mokraće.
• While using Sixmo, situations may arise where you need acute pain treatment or anaesthesia.
Sixmo mogu nastati situacije u kojima će Vam biti potrebno liječenje bola ili anestezija.
• Other CNS depressants: Other opioid derivatives (e.g. methadone, analgesics and antitussives), certain antidepressants, sedative H1-receptor antagonists, barbiturates, anxiolytics other than benzodiazepines, neuroleptics, clonidine and related substances: these combinations increase CNS depression.
određeni antidepresivi, sedativni antagonisti H1-receptora, barbiturati, anksiolitici koji ne pripadaju skupini benzodiazepina, neuroleptici, klonidin i slične tvari: te kombinacije pojačavaju depresiju SŽS-a.
Table 3: Percentage of Opioid-Negative Urine Samples for Weeks 1 to 16 and Weeks 17 to 24,
Tablica 3: Postotak uzoraka mokraće negativnih na opioide od 1. do 16. tjedna i od 17. do 24.
Step 16: After removal of each implant, confirm that the entire 26.5 mm long implant has been removed by measuring its length.
Korak 16: Nakon uklanjanja pojedinog implantata, provjerite da je isti uklonjen u cjelini tako što ćete mu izmjeriti duljinu, koja iznosi 26,5 mm.
• dry mouth, wind, indigestion, bloody stool
• suha usta, vjetrovi, probavne smetnje, krvava stolica
• The other ingredient is ethylene vinyl acetate copolymer.
• Drugi sastojak je etilenvinilacetat kopolimer.
• changes in blood levels increased enzyme levels: aspartate aminotransferase, gamma-glutamyltransferase, blood lactate dehydrogenase, lipase, amylase decreased enzyme levels: alkaline phosphatase increased bicarbonate level increased bilirubin level - a yellow breakdown substance of the blood pigment increased glucose level decreased cholesterol level decreased haematocrit - the percentage of blood cells on the blood volume decreased haemoglobin - the red blood cell pigment, increased mean cell haemoglobin increase in certain white blood cell count: monocyte, neutrophils decreased cell count: platelets, red blood cells, lymphocytes
• promjene na krvnim pretragama - povišene razine enzima: aspartat aminotransferaze, gama-glutamiltransferaze, laktat dehidrogenaze u krvi, lipaze, amilaze - snižene razine enzima: alkalne fosfataze - povišena razina bikarbonata - povišena razina bilirubina - žute tvari koja nastaje razgradnjom krvnog pigmenta - povišena razina glukoze - snižena razina kolesterola - sniženi hematokrit - postotak volumena krvi koji otpada na krvne stanice - sniženi hemoglobin - pigment u crvenim krvnim stanicama, povišena srednja vrijednost staničnog hemoglobina - povećan broj određenih bijelih krvnih stanica: monocita, neutrofila - sniženi broj stanica: krvnih pločica, crvenih krvnih stanica, limfocita
Improper insertions or infections may lead to protrusion or expulsion.
Neispravna ugradnja ili infekcije mogu dovesti do protruzije ili do izbacivanja implantata.
Patients who discontinue treatment with Sixmo should be switched back to their previous dose of sublingual buprenorphine within 12 to 24 hours following removal of the Sixmo implants (i.e. the dose from which they were transferred prior to starting Sixmo treatment).
Prekid liječenja Bolesnici koji prekinu liječenje implantatom Sixmo trebaju se, unutar 12-24 sata od uklanjanja implantata Sixmo, vratiti na dozu sublingvalnog buprenorfina koju su prethodno uzimali (tj. na dozu koju su uzimali neposredno prije nego što su prebačeni na liječenje implantatom Sixmo).
Blood and lymphatic system disorders uncommon lymphadenopathy, neutropenia
Poremećaji krvi i limfnog sustava manje često limfadenopatija, neutropenija
Naloxone may be of value for the management of buprenorphine overdose.
Nalokson može biti koristan u zbrinjavanju predoziranja buprenorfinom.
Figure 2: Cumulative Distribution Function of the Percentage of Urine Samples Negative for Opioids in Weeks 1-24 (co-primary endpoint 1), Study PRO-806 (ITT Population)
Slika 2: Kumulativna funkcija distribucije postotka uzoraka mokraće negativnih na opioide u razdoblju od 1. do 24. tjedna (1. primarna mjera ishoda), ispitivanje PRO-806 (ITT populacija)
How to store Sixmo
Kako primjenjivati Sixmo
Apply the sterile fenestrated drape to the patient's arm (Figure 4).
Prekrijte ruku bolesnika sterilnom prekrivkom s otvorom (slika 4).
Risk of serious complications of insertion and removal of implants Rare but serious complications including nerve damage and migration resulting in embolism and death may result from improper insertion of drug implants (see section 4.4).
Rijetke, ali ozbiljne komplikacije uključujući oštećenje živca i migraciju implantata s posljedičnom embolijom i smrću mogu biti rezultat neispravne ugradnje implantata s lijekom (vidjeti dio 4.4).
• sedation
• sedaciju
Patients receiving Sixmo should be closely monitored for signs of toxicity if combined with potent CYP3A4 inhibitors (e.g. protease inhibitors like ritonavir, nelfinavir or indinavir, or azole antifungals such as ketoconazole and itraconazole, or macrolide antibiotics).
Sixmo kombinira s potentnim inhibitorima CYP3A4 (npr. inhibitorima proteaze kao što su ritonavir, nelfinavir ili indinavir ili azolnim antimikoticima kao što su ketokonazol i itrakonazol ili makrolidnim antibioticima).
• infection, such as viral infection (e.g. flu)
• infekcija, kao što je virusna infekcija (npr. gripa) • kašalj, nedostatak zraka
4 years.
6.3 Rok valjanosti 4 godine.
After removal of the implant, the doctor will apply a sterile gauze with a pressure bandage to minimize bruising.
Nakon uklanjanja implantata, liječnik će staviti sterilnu gazu s kompresijskim zavojem da bi smanjio podljev.
In each of the two studies, the proportion of subjects requiring supplemental SL BPN was significantly higher in the placebo group than in the Sixmo group (90.9% and 66.7% of subjects, with mean days of use per week of 2.17 and 1.27, in PRO-805 and PRO-806, respectively).
Sixmo značajno viši u skupini koja je dobila placebo nego u skupini koja je dobila Sixmo (90,9% odnosno 66,7% ispitanika, uz srednju vrijednost broja dana uporabe tjedno od 2,17 odnosno 1,27 u ispitivanjima PRO-805 i PRO-806).
• alcohol pad
• alkoholni tupfer
Implant kit: 4 Sixmo implants with 1 applicator
Implantacijski set: 4 implantata Sixmo s 1 aplikatorom 6.6 Posebne mjere za zbrinjavanje
Priorities are the re-establishment of a patient and protected airway and institution of assisted ventilation, if needed.
Na prvom je mjestu ponovna uspostava prohodnosti i zaštite dišnih putova i, po potrebi, uvođenje potpomognute ventilacije.
• other medicines that depress the brain or spinal cord, as these reduce alertness, making driving and using machines hazardous other opioid derivatives such as methadone, strong painkillers and cough suppressants certain medicines to treat depressions medicines called antihistamines used to treat allergic reactions, sleep disturbances, cold; or prevent and treat nausea and vomiting medicines to treat epilepsy or to sedate, with active substance names mostly ending with “tal” medicines to treat anxiety, other than those described in the first bullet point medicines to treat mental or anxiety disorders, with sedative effects, called neuroleptics clonidine: a medicine to treat high blood pressure and high eye pressure
• druge lijekove s depresornim učinkom na funkciju mozga ili leđne moždine jer smanjuju budnost, zbog čega je opasno upravljati vozilima i strojevima druge opioidne derivate poput metadona, jakih analgetika i lijekova protiv kašlja određene lijekove za liječenje depresije lijekove pod nazivom antihistaminici koji se primjenjuju za liječenje alergijskih reakcija, poremećaja spavanja, prehlade; ili za sprječavanje i liječenje mučnine i povraćanja lijekove za liječenje epilepsije ili za sedaciju, s djelatnim tvarima čiji nazivi većinom završavaju na “tal”
Keep this medicine out of the sight and reach of children.
Kako čuvati Sixmo Lijek čuvajte izvan pogleda i dohvata djece.
Figure 3: Plasma buprenorphine concentrations after insertion of Sixmo (concentrations up to day 28 are based on study PRO-810, while concentrations after day 28 are based on studies PRO-805, PRO-806, PRO-807 and PRO-811)
Slika 3: Koncentracije buprenorfina u plazmi nakon ugradnje implantata Sixmo (koncentracije do 28. dana temelje se na ispitivanju PRO-810, dok se koncentracije nakon 28. dana temelje na ispitivanjima PRO-805, PRO-806, PRO-807 i PRO-811)
Opioids have been shown to increase intracholedochal pressure, and should be used with caution in patients with dysfunction of the biliary tract.
Pokazalo se da opioidi povećavaju tlak u žučovodu pa se moraju primjenjivati s oprezom u bolesnika s poremećenom funkcijom žučnih putova.
Place the implant in a glass jar with a lid. Store it safely away from others, especially children.
Spremite je na sigurno mjesto izvan dohvata drugih, osobito djece.
• If the expelled implant is not intact, the healthcare professional should palpate the insertion location to identify the location of any remaining partial implant.
• Ako nije izbačen cijeli implantat, liječnik treba palpacijom mjesta ugradnje utvrditi gdje se nalazi preostali dio implantata.
Buprenorphine should be used cautiously when co-administered with:
Buprenorfin se ne smije primjenjivati zajedno s:
Sixmo implants must be inserted, removed, and patients monitored by a healthcare professional familiar with the procedure, with experience in the management of opioid addiction.
Sixmo implantate mora ugraditi i ukloniti, a bolesnika pratiti liječnik koji je upoznat s postupkom i ima iskustva u liječenju ovisnosti o opioidima.
Step 4: Lift the edge of the incision opening with the toothed forceps.
Korak 4: Podignite rub otvora incizije kirurškom pincetom.
Apply an ice pack on the arm for 40 minutes every two hours for the first 24 hours, then as needed.
24 sata stavlja hladni oblog na ruku svaka dva sata i drži ga 40 minuta, a poslije po potrebi.
Follow steps 15 and 16 for the removal of the remaining implants through the same incision.
Za uklanjanje preostalih implantata kroz istu inciziju slijedite korake 15 i 16.
• latex, talc-free sterile gloves
• sterilne rukavice od lateksa, bez talka
• pain affecting muscles and skeleton, neck, limbs, joints
• bol u mišićima i kostima, vratu, udovima, zglobovima
• hot flush, bruising, dilation of blood vessels
• navale vrućine, modrice, širenje krvnih žila
Nervous system disorders common headache, dizziness, somnolence, hypertonia**, syncope** uncommon hypoaesthesia, migraine, depressed level of consciousness, hypersomnia, paraesthesia, tremor
Poremećaji živčanog sustava često glavobolja, omaglica, somnolencija, hipertonija**, sinkopa** manje često hipoestezija, migrena, snižena razina svijesti, hipersomnija, parestezija, tremor
Buprenorphine is extensively metabolized in the liver.
Oštećenje jetrene funkcije Buprenorfin se opsežno metabolizira u jetri.
Appropriate precautions, such as the conduct of patient follow-up visits according to the patient's needs and the treating physician's clinical judgement, should be taken during Sixmo treatment.
Sixmo moraju se provoditi odgovarajuće mjere opreza, kao što su kontrolni pregledi bolesnika prema njihovim potrebama i kliničkoj procjeni liječnika koji provodi liječenje.
• consistency in compliance with clinic visit requirements
• dosljedno pridržavanje obaveze redovitih posjeta liječniku
Withdraw the cannula until the hub is flush with the obturator, then twist the obturator clockwise to lock onto the cannula (Figure 12).
Povlačite kanilu sve dok ne bude ispunjena opturatorom, a zatim zakrenite opturator u smjeru kazaljke na satu da se pričvrsti za kanilu (slika 12).
• a history of connective tissue disease such as scleroderma • a history of recurrent methicillin-resistant Staphylococcus aureus infections (MRSA)
• u anamnezi imate ponavljajuće infekcije uzrokovane bakterijom Staphylococcus aureus rezistentnom na meticilin (MRSA)
Adverse drug reactions were categorized as implant or non-implant adverse reactions.
Nuspojave su bile kategorizirane kao nuspojave implantata ili nuspojave djelatne tvari.
• rash, rash pustular, skin lesion
• osip, pustulozni osip, kožna lezija
The efficacy and safety of buprenorphine in elderly patients > 65 years has not been established.
Djelotvornost i sigurnost buprenorfina u starijih bolesnika u dobi
Mean plasma buprenorphine concentrations up to day 28 are based on data from the relative bioavailability study PRO-810 (which had intensive PK sampling), while concentrations after day 28 are based on pooled data from studies PRO-805, PRO-806, PRO-807 and PRO-811.
Srednje vrijednosti koncentracija buprenorfina u plazmi do 28. dana temelje se na podacima iz ispitivanja relativne bioraspoloživosti PRO-810 (u kojem se provodilo intenzivno uzimanje uzoraka za farmakokinetičku analizu), dok su koncentracije nakon 28. dana bile temeljene na objedinjenim podacima iz ispitivanja PRO-805, PRO-806, PRO-807 i PRO-811.
Reproductive system and breast disorders uncommon dysmenorrhoea, erectile dysfunction
Poremećaji reproduktivnog sustava i dojki manje često dismenoreja, erektilna disfunkcija
• Avoid moving implants around under the skin or gain a lot of weight after insertion of Sixmo as this may make it difficult to locate implants.
Sixmo izbjegavajte pomicati implantate ispod kože ili se jako udebljati jer to može otežati pronalaženje mjesta na kojem se nalaze implantati.
Mean steady-state plasma buprenorphine concentrations were consistent across all clinical studies, at approximately 0.5 to 1 ng/mL (with the 4-implant dose), and were maintained for approximately 20 weeks (week 4 through week 24) in a 24-week treatment period.
Srednja vrijednost koncentracije buprenorfina u plazmi u stanju dinamičke ravnoteže bila je slična u svim kliničkim ispitivanjima i iznosila je približno 0,5-1 ng/ml (uz dozu 4 implantata), a održala se tijekom približno 20 tjedana
The concomitant use of monoamine oxidase inhibitors (MAOI) might produce an exaggeration of the effects of opioids, based on experience with morphine (see section 4.5).
Na temelju iskustva s morfinom, istodobna primjena inhibitora monoaminoksidaze (MAO) mogla bi pojačati učinke opioida (vidjeti dio 4.5).
Metabolites of buprenorphine accumulate in patients with renal failure.
Metaboliti buprenorfina nakupljaju se u bolesnika s bubrežnim zatajenjem.
Implants should be removed under aseptic conditions, whereby the following equipment is needed:
Za ugradnju implantata u aseptičkim uvjetima potrebna je sljedeća oprema:
Table 5: Implant breakage in Sixmo double-blind Phase 3 studies Current technique and training PRO-806
Tablica 5: Lomljenje implantata Sixmo u dvostruko slijepim ispitivanjima faze 3
Plasma concentrations of buprenorphine after insertion of Sixmo are highest during the first 24 to 48 hours.
Sixmo najviše su tijekom prvih 24-48 sati.
This should be stopped 12 to 24 hours before insertion of the next set of Sixmo implants.
Tu primjenu treba prekinuti 12-24 sata prije ugradnje sljedećeg kompleta implantata Sixmo.
Vascular disorders common hot flush, vasodilatation**, hypertension**
Krvožilni poremećaji često navale vrućine, vazodilatacija**, hipertenzija**
• signs of intoxication or overdose appear (miosis, lip cyanosis, sedation, bradycardia,
• ako se pojave znakovi intoksikacije ili predoziranja (mioza, cijanoza usana, sedacija, bradikardija, hipotenzija, respiratorna depresija);
After insertion of the implants, the doctor will apply a sterile gauze with a pressure bandage to minimize bruising.
Nakon ugradnje implantata liječnik će staviti sterilnu gazu s kompresijskim zavojem da bi smanjio podljev.
Investigations common alanine aminotransferase increased uncommon aspartate aminotransferase increased, weight decreased, blood lactate dehydrogenase increased, gamma-glutamyl-transferase increased, weight increased, blood alkaline phosphatase decreased, amylase increased, blood bicarbonate increased, blood bilirubin increased, blood cholesterol decreased, blood glucose increased, haematocrit decreased, haemoglobin decreased, lipase increased, lymphocyte count decreased, mean cell haemoglobin increased, mean cell volume abnormal, monocyte count increased, neutrophil count increased, platelet count decreased, red blood cell count decreased
Pretrage često povišena vrijednost alanin aminotransferaze manje često povišena vrijednost aspartat aminotransferaze, smanjena tjelesna težina, povišena vrijednost laktat dehidrogenaze u krvi, povišena vrijednost gama-glutamiltransferaze, povećana tjelesna težina, snižena vrijednost alkalne fosfataze, povišena vrijednost amilaze, povišena vrijednost bikarbonata u krvi, povišena vrijednost bilirubina u krvi, snižena vrijednost kolesterola u krvi, povišena vrijednost glukoze u krvi, sniženi hematokrit, sniženi hemoglobin, povišena vrijednost lipaze, snižen broj limfocita, povećana srednja vrijednost hemoglobina u eritrocitu, poremećena srednja vrijednost volumena eritrocita, povećan broj monocita, povećan broj neutrofila, snižen broj trombocita, snižen broj eritrocita
• Please note that an ultrasound and MRI facilities need to be available to the clinical site at which the insertion and removal of Sixmo occurs.
• Napominjemo da na klinici gdje se ugrađuju i uklanjaju implantati Sixmo moraju biti dostupni uređaji za ultrazvuk i magnetsku rezonanciju (MR).
Step 3: Put on sterile gloves and check the function of the implant applicator by removing the obturator from the cannula and relocking it. Clean the insertion site with an antiseptic solution, such as chlorhexidine.
Korak 3: Navucite sterilne rukavice i provjerite funkciju aplikatora implantata tako što ćete izvaditi opturator iz kanile i onda ga vratiti i pričvrstiti.
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING Sachet
PODACI KOJI SE MORAJU NALAZITI NA UNUTARNJEM PAKIRANJU
Buprenorphine is extensively metabolized in the liver and increased plasma levels were found to be increased in patients with moderate and severe hepatic impairment.
Buprenorfin se opsežno metabolizira u jetri i u bolesnika s umjerenim i teškim oštećenjem jetrene funkcije pronađene su povišene razine u plazmi.
• One applicator is used to insert all four implants.
• Za ugradnju sva četiri implantata koristi se jedan aplikator.
Place an adhesive bandage over the incision.
Preko incizije stavite flaster.
Implants for repeat treatment should be inserted subcutaneously as soon as possible after removal of the previous implants, preferably on the same day.
Nakon uklanjanja prethodnih implantata, implantate za ponovno liječenje treba ugraditi supkutano čim prije, po mogućnosti isti dan.
In case toxicity or overdose symptoms are observed, the removal of the implants and transition to a medicinal product that allows dose adjustment are required.
U slučaju da se opaze simptomi toksičnosti ili predoziranja, potrebno je ukloniti implantate i prebaciti bolesnika na lijek kod kojeg je moguća prilagodba doze.
Opioids may produce orthostatic hypotension in ambulatory patients.
Opioidi mogu izazvati ortostatsku hipotenziju u bolesnika koji nisu vezani za krevet.
In case toxicity or overdose symptoms develop, the removal of the implants and transition to a medicinal product that allows dose adjustment are required.
U slučaju da se razviju znakovi i simptomi toksičnosti ili predoziranja, implantate se mora ukloniti i bolesnika prebaciti na lijek koji omogućuje prilagodbu doze.
• Implants are located under the skin, at the inner side of the upper arm.
• Implantati su smješteni potkožno s unutarnje strane nadlaktice.
Alternatively, replacement implant(s) may be inserted in the contralateral arm.
Druga je mogućnost ugraditi zamjenski implantat (ili više njih) u suprotnu ruku.
Buprenorphine given under the tongue will be stopped 12 to 24 hours before insertion of Sixmo implants.
Primjena buprenorfina koji se daje pod jezik prekinut će se 12-24 sata prije ugradnje implantata Sixmo.
In the analysis of the CDF (weeks 1 to 16), a statistically significant difference between treatments (p=0.0361) was seen, which was in favour of Sixmo.
U analizi KFD-a (od 1. do 16. tjedna) opažena je statistički značajna razlika između terapija
One applicator is used to insert all four implants.
Za ugradnju sva četiri implantata koristi se jedan aplikator.
Modification of the Sixmo dose is not required in patients with renal impairment.
Nije potrebna prilagodba doze implantata Sixmo u bolesnika s oštećenjem bubrežne funkcije.
A mass balance study of buprenorphine showed complete recovery of radiolabel in urine (30%) and faeces (69%) collected up to 11 days after dosing.
(30%) i stolici (69%) prikupljenima do 11. dana nakon doziranja.
Higher doses may be required for analgesic effect.
Za analgetski učinak mogu biti potrebne više doze pa stoga uz primjenu opioida postoji veća mogućnost toksičnosti.
Step 13: The patient should lie on their back, with the implant arm flexed at the elbow and externally rotated, so that the hand is positioned next to the head.
Korak 13.: Bolesnik mora ležati na leđima, a ruka u koju će se ugraditi implantat mora biti savijena u laktu i rotirana prema van, tako da mu šaka bude pozicionirana pokraj glave.
PATIENT ALERT CARD
Kartica s upozorenjima za bolesnika